Maricic, Michael

New and emerging treatments for osteoporosis. [electronic resource] - Current opinion in rheumatology Jul 2007 - 364-9 p. digital

Publication Type: Journal Article; Review

1040-8711

10.1097/BOR.0b013e328172dc1a doi


Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Bone Density--drug effects
Bone Density Conservation Agents--adverse effects
Clinical Trials, Phase III as Topic
Denosumab
Diphosphonates--adverse effects
Drug Administration Routes
Drug Administration Schedule
Female
Humans
Ibandronic Acid
Imidazoles--adverse effects
Osteoporosis, Postmenopausal--drug therapy
Patient Compliance
RANK Ligand
Zoledronic Acid